Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial.
Yu KD, Liu XY, Chen L, Mo M, Wu J, Liu GY, Di GH, Verschraegen C, Stover DG, Zhuang ZG, Bertucci F, Orlandi A, Wang J, Lippi G, Wu KJ, Osman MA, Fan L, Shao ZM.
Yu KD, et al. Among authors: wu kj, wu j.
Lancet Reg Health West Pac. 2021 May 13;11:100158. doi: 10.1016/j.lanwpc.2021.100158. eCollection 2021 Jun.
Lancet Reg Health West Pac. 2021.
PMID: 34327363
Free PMC article.